Page 264 - Haematologica April 2020

S.I. Obydennyi et al.
al. Alterations in the parameters of classic, global, and innovative assays of hemostasis caused by sample transportation via pneu- matic tube system. Thromb Res. 2018;170: 156-164.
25. Podoplelova NA, Sveshnikova AN, Kotova YN, et al. Coagulation factors bound to pro- coagulant platelets concentrate in cap struc- tures to promote clotting. Blood. 2016;128 (13):1745-1755.
26. Shakhidzhanov SS, Shaturny VI, Panteleev MA, Sveshnikova AN. Modulation and pre- amplification of PAR1 signaling by ADP act- ing via the P2Y12 receptor during platelet subpopulation formation. Biochim Biophys Acta. 2015;1850(12):2518-2529.
27. Sveshnikova AN, Balatskiy AV, Demianova AS, et al. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling. J Thromb Haemost. 2016;14(10):2045-2057.
28. Suntsova EV, Demina IM, Ignatova AA, et al. Bleeding tendency and platelet function during treatment with romiplostim in chil- dren with severe immune thrombocy- topenic purpura. Int J Hematol. 2017;105 (6):841-848.
29. Ignatova AA, Ponomarenko EA, Polokhov
DM, et al. Flow cytometry for pediatric
platelets. Platelets. 2019;30(4):428-437.
30. Rodeghiero F, Pecci A, Balduini CL. Thrombopoietin receptor agonists in hered- itary thrombocytopenias. J Thromb
Haemost. 2018;16(9):1700-1710.
31. Gerrits AJ, Leven EA, Frelinger AL, 3rd, et al. Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syn- drome/X-linked thrombocytopenia. Blood.
2015;126(11):1367-1378.
32. Heemskerk JW, Hoyland J, Mason WT, Sage
SO. Spiking in cytosolic calcium concentra- tion in single fibrinogen-bound fura-2- loaded human platelets. Biochem J. 1992;283 ( Pt 2):379-383.
33. Sveshnikova AN, Ataullakhanov FI, Panteleev MA. Compartmentalized calcium signaling triggers subpopulation formation upon platelet activation through PAR1. Mol Biosyst. 2015;11(4):1052-1060.
34. Kholmukhamedov A, Janecke R, Choo HJ, Jobe SM. The mitochondrial calcium uni- porter regulates procoagulant platelet forma- tion. J Thromb Haemost. 2018;16(11):2315- 2321.
35. Ignatova A, Suntsova E, Zharkov P, et al. Evolution of platelet function and bleeding
in children and adults with chronic immune trombocytopenia on romiplostim treatment. Blood. 2017;130(Suppl 1):3636.
36. Jobe SM, Wilson KM, Leo L, et al. Critical role for the mitochondrial permeability tran- sition pore and cyclophilin D in platelet acti- vation and thrombosis. Blood. 2008;111(3): 1257-1265.
37. Alberio L, Ravanat C, Hechler B, Mangin PH, Lanza F, Gachet C. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation. Thromb Haemost. 2017;117(6):1101-1114.
38. Mangin PH, Onselaer MB, Receveur N, et al. Immobilized fibrinogen activates human platelets through glycoprotein VI. Haematologica. 2018;103(5):898-907.
39. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood. 2000;95(5):1694-1702.
40. Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich syndrome: diag- nosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15(1 Suppl):84-90.
1106
haematologica | 2020; 105(4)